This event is part of the TUM-IAS Focal Period "Clinical Cell and Tissue Engineering"
Date: 17th-18th of March 2016
Location: Klinikum rechts der Isar, Munich
The meeting intends to discuss the state of the art of adoptive T cell therapy using unmodified as well as T cell- and chimeric antigen receptor gene-modified T cells and immunological mechanisms underlying T cell therapy.
Organizers:
- Prof. Dr. Dirk Busch, Institut für medizinische Mikrobiologie, Immunologie und Hygiene
- Prof. Dr. Thomas Blankenstein, Max-Delbrück-Center for Molecular Medicine (MDC)
- Prof. Dr. Wolfgang Uckert, Max-Delbrück-Center for Molecular Medicine (MDC)
More information can be found here.